BDC Laboratories Releases Stent, Stent Graft, And Transcatheter Heart Valve Simulated Use Test Systems
Main Category: VascularAlso Included In: Cardiovascular / Cardiology; Medical Devices / Diagnostics
Article Date: 15 Jun 2011 - 5:00 PDT
'BDC Laboratories Releases Stent, Stent Graft, And Transcatheter Heart Valve Simulated Use Test Systems'
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Endovascular stents, stent grafts, and transcatheter heart valve (TAVI) devices provide enhanced methods for clinical treatment of cardiac and vascular disease. Further research and product development is currently ongoing worldwide to address complications associated with these devices. BDC Laboratories has released new technology to aid the medical device industry with their product design testing by providing physiologic simulated use test systems.
"Our technology will assist the medical device industry with their functional design testing for stents, stent grafts, and transcatheter heart valve devices. BDC's simulated use test systems provide an easy, controlled, and cost-effective means for R&D engineers to assess their technologies in a clinically relevant manner."
Simulated use testing provides the ability to study critical stent, stent graft, and TAVI heart valve device delivery system characteristics and design parameters in a predictable, controlled, and reproducible manner. BDC Laboratories' simulated use test systems aid in the evaluation of product designs and delivery system parameters by emulating physiological hemodynamics and vascular or cardiac anatomy and compliance.
Key device attributes that can be evaluated with simulated use testing include pulsatile flow device interactions, stent, stent graft, and cardiac device implant positioning, implant deployment accuracy, implant sizing, conformability of the implant to the vessel wall, heart valve in valve deployment, delivery system trackability, pushability, and torquability as outlined in the ISO 25539 and ISO 5840 guidance documents.
Craig Weinberg, Ph.D., one of the principals of BDC Labs said, "Our technology will assist the medical device industry with their functional design testing for stents, stent grafts, and transcatheter heart valve devices. BDC's simulated use test systems provide an easy, controlled, and cost-effective means for R&D engineers to assess their technologies in a clinically relevant manner."
Source:
Biomedical Device Consultants and Laboratories
Visit our vascular section for the latest news on this subject.
MLA
26 May. 2012. <http://www.medicalnewstoday.com/releases/228604.php>
APA
http://www.medicalnewstoday.com/releases/228604.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'BDC Laboratories Releases Stent, Stent Graft, And Transcatheter Heart Valve Simulated Use Test Systems'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




